Document ID: chunk:federal_register_of_legislation:F2019L00947:reg:9:p1
Version: federal_register_of_legislation:F2019L00947
Segment Type: reg
Provision Reference: reg 9 (pt 1/2)
Character Range: 3617–6670

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting subarachnoid haemorrhage or death from subarachnoid haemorrhage with the circumstances of a person's relevant service:
(1)          undertaking physical activity of at least six METs within the two hours before the clinical onset of subarachnoid haemorrhage;
Note:  MET is defined in the Schedule 1 - Dictionary.
(2)          having concussion or moderate to severe traumatic brain injury within the 30 days before the clinical onset of subarachnoid haemorrhage;
(3)          having hypertension at the time of the clinical onset of subarachnoid haemorrhage;
(4)          having pregnancy-induced hypertension at the time of the clinical onset of subarachnoid haemorrhage;
(5)          undergoing childbirth or being within six weeks postpartum at the time of the clinical onset of subarachnoid haemorrhage;
(6)          smoking at least one pack-year of cigarettes, or the equivalent thereof in other tobacco products, before the clinical onset of subarachnoid haemorrhage, and where smoking has ceased, the clinical onset of subarachnoid haemorrhage has occurred within ten years of cessation;
Note:  pack-year of cigarettes, or the equivalent thereof in other tobacco products is defined in the Schedule 1 - Dictionary.
(7)          undergoing antithrombotic therapy within the two weeks before the clinical onset of subarachnoid haemorrhage;
Note:  antithrombotic therapy is defined in the Schedule 1 - Dictionary.
(8)          taking at least 700 milligrams of aspirin within a seven day period before the clinical onset of subarachnoid haemorrhage, and where the last dose of aspirin was taken no more than seven days before the clinical onset of subarachnoid haemorrhage;
(9)          having infective intracranial vasculitis at the time of the clinical onset of subarachnoid haemorrhage;
(10)      having an inflammatory vascular disease from the specified list of inflammatory vascular diseases affecting the cerebral vessels at the time of the clinical onset of subarachnoid haemorrhage;
Note:  specified list of inflammatory vascular diseases is defined in the Schedule 1 - Dictionary.
(11)      for males, consuming an average of at least 150 grams of alcohol per week for a continuous period of at least the six months before the clinical onset of subarachnoid haemorrhage;
Note:  Alcohol consumption is calculated utilising the Australian Standard of ten grams of alcohol per standard alcoholic drink.
(12)      for females, consuming an average of at least 110 grams of alcohol per week for a continuous period of at least the six months before the clinical onset of subarachnoid haemorrhage;
Note:  Alcohol consumption is calculated utilising the Australian Standard of ten grams of alcohol per standard alcoholic drink.
(13)      using a drug from the specified list of drugs within the 72 hours before the clinical onset of subarachnoid haemorrhage;
Note: